Current dividend yield | 8.67 % |
Dividendenrendite 5 Jahre | 6.84 % |
Dividend Yield 10Y | 8.94 % |
Payout 3Y | 5.23 % |
Year | Dividend | Ex-day & Payday |
Frequency | |
---|---|---|---|---|
Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
2023 |
$3.6147
$3.61
|
Mar 08 2023
Mar 08 2023
Mar 08 2023
Mar 08 23
Mar 08 23 |
Mar 08 2023 |
Special dividend
Special div.
|
2023 |
$1.5348
$1.53
|
Mar 06 2023
Mar 06 2023
Mar 10 2023
Mar 06 23
Mar 10 23 |
Mar 10 2023 |
Special dividend
Special div.
|
Carisma Therapeutics most recently paid a dividend of $3.61. Carisma Therapeutics paid a Dividend of $0.00 Per Share in the financial year 2023. With a stock price of $0.94 at Nov 14 2024, the current dividend yield is 0.00% (calculation: $0.00 / $0.94 = 0.00%). A Special Dividend was paid in the amount of $5.15 Per Share. Special dividends are not included in the calculation of the dividend yield.
The average Carisma Therapeutics dividend yield over the last 5 years is 0.00% and the average over the last 10 years is 0.00%.
The payout ratio of Carisma Therapeutics in relation to the last financial year is -198.82%. The payout ratio smoothed over 3 years is -0.89%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
Metric | Carisma Therapeutics |
---|---|
Current dividend yield | 0.00% |
Dividend Yield 5Y | 0.00% |
Dividend Yield 10Y | 0.00% |
Payout 1Y | -198.82% |
Payout 3Y | -0.89% |
Carisma Therapeutics has been paying a dividend since 1 and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
Metric | Carisma Therapeutics |
---|---|
Increased | 1 Year |
Continuity | 1 Year |
Paid | 1 Year |
Carisma Therapeutics has been paying a dividend since 1 and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
On the stock exchange, the Carisma Therapeutics stock (ISIN: US14216R1014) is not traded as a top scorer in November 2024 according to the dividend strategy.
The stock price of Carisma Therapeutics -69.86% has fallen since the beginning of the year 2024. However, the return generated in the past says nothing about the future return. You can find the Carisma Therapeutics stock price in real time at the top of the page.
Carisma Therapeutics (symbol: CARM) is valued at a Price / Earnings Ratio (P/E ratio) of -0.60 and a price/sales ratio (P/S ratio) of 1.93 valued. Based on analyst estimates, the Carisma Therapeutics stock forecast 2024 of the current financial year corresponds to a valuation of -0.81 according to P/E ratio and 1.83 according to P/S.
Metric | Carisma Therapeutics |
---|---|
Dividend Score | ??/15 |
Performance 2024 |
69.86%
|
P/E TTM | -0.60 |
P/S TTM | 1.93 |
P/E forward | -0.81 |
P/S forward | 1.83 |
Carisma Therapeutics (symbol: CARM) is valued at a Price / Earnings Ratio (P/E ratio) of -0.60 and a price/sales ratio (P/S ratio) of 1.93 valued. Based on analyst estimates, the Carisma Therapeutics stock forecast 2024 of the current financial year corresponds to a valuation of -0.81 according to P/E ratio and 1.83 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.